Day One Company Leadership

DAWN Stock  USD 13.72  0.38  2.85%   
Day One's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Day One Biopharmaceuticals suggests that virtually all insiders are panicking. Day One employs about 174 people. The company is managed by 13 executives with a total tenure of roughly 406 years, averaging almost 31.0 years of service per executive, having 13.38 employees per reported executive.

Day One's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-11-11Samuel C BlackmanDisposed 10000 @ 16.1View
2024-11-07Samuel C BlackmanDisposed 11245 @ 16.03View
2024-10-31Samuel C BlackmanDisposed 500 @ 16.02View
2024-09-10Samuel C BlackmanDisposed 30000 @ 14.22View
2024-08-16Samuel C BlackmanDisposed 2232 @ 14View
2024-07-16Samuel C BlackmanDisposed 20000 @ 16.01View
2024-06-21Saira RamasastryDisposed 10000 @ 13.19View
2024-05-16Samuel C BlackmanDisposed 2267 @ 16.08View
2024-05-10Samuel C BlackmanDisposed 10000 @ 16.37View
2024-05-03Jeremy BenderDisposed 9154 @ 17.85View
2024-05-01Jeremy BenderDisposed 70051 @ 17.88View
2024-04-18Samuel C BlackmanDisposed 10000 @ 16.02View
Monitoring Day One's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Day One Biopharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

Day One Management Team Effectiveness

The company has return on total asset (ROA) of (0.2543) % which means that it has lost $0.2543 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1784) %, meaning that it created substantial loss on money invested by shareholders. Day One's management efficiency ratios could be used to measure how well Day One manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of November 2024, Return On Tangible Assets is likely to drop to -0.53. In addition to that, Return On Capital Employed is likely to drop to -0.62. At this time, Day One's Net Tangible Assets are very stable compared to the past year. As of the 25th of November 2024, Non Currrent Assets Other is likely to grow to about 263.7 K, while Total Assets are likely to drop about 239.3 M.
As of the 25th of November 2024, Common Stock Shares Outstanding is likely to drop to about 72.8 M. In addition to that, Net Loss is likely to drop to about (134.4 M)

Day One Workforce Comparison

Day One Biopharmaceuticals is rated # 2 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 673. Day One totals roughly 174 in number of employees claiming about 26% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.83) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.32 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.32.

Day One Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Day One insiders, such as employees or executives, is commonly permitted as long as it does not rely on Day One's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Day One insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-12-01
0.6
12
20
 47,334 
 105,861 
2024-09-01
0.7727
17
22
 1,116,832 
 357,994 
2024-06-01
0.7692
20
26
 306,014 
 263,074 
2024-03-01
1.1579
22
19
 1,315,654 
 123,115 
2023-12-01
0.6875
11
16
 1,503,615 
 459,996 
2023-09-01
0.7143
10
14
 584,812 
 829,686 
2023-06-01
1.4
14
10
 1,046,291 
 20,541 
2023-03-01
0.5455
12
22
 581,561 
 168,564 
2022-12-01
0.1034
3
29
 6,124 
 763,656 
2022-09-01
0.0484
3
62
 41,586 
 6,306,118 
2022-06-01
16.0
16
1
 5,015,701 
 50,000 
2022-03-01
4.5
9
2
 887,862 
 10,000 
2021-12-01
0.1667
2
12
 1,057,224 
 3,290,620 
2021-09-01
1.0
1
1
 48,072 
 0.00 
2021-06-01
0.5484
17
31
 33,312,285 
 58,304,213 

Day One Notable Stakeholders

A Day One stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Day One often face trade-offs trying to please all of them. Day One's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Day One's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jeremy MBAPresident CEOProfile
MBA IICFO COOProfile
PharmD ChiodinChief OfficerProfile
Jaa RobersonChief OfficerProfile
Elly MDChief OfficerProfile
Adam DubowGeneral CounselProfile
Lauren MBAChief OfficerProfile
Adam JDGeneral OfficerProfile
Mike PreighChief OperationsProfile
Charles IICFO COOProfile
John StubenrauchChief OfficerProfile
Julie MBACoFounder DirectorProfile
Prof MDChief OfficerProfile

About Day One Management Performance

The success or failure of an entity such as Day One Biopharmaceu often depends on how effective the management is. Day One management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Day management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Day management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.50)(0.53)
Return On Capital Employed(0.59)(0.62)
Return On Assets(0.50)(0.53)
Return On Equity(0.55)(0.52)

Day One Workforce Analysis

Traditionally, organizations such as Day One use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Day One within its industry.

Day One Manpower Efficiency

Return on Day One Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.1M
Net Loss Per Executive14.5M
Working Capital Per Employee2M
Working Capital Per Executive26.6M
When determining whether Day One Biopharmaceu offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Day One's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Day One Biopharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Day One Biopharmaceuticals Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Day One Biopharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Day One. If investors know Day will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Day One listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.97)
Revenue Per Share
1.144
Return On Assets
(0.25)
Return On Equity
(0.18)
The market value of Day One Biopharmaceu is measured differently than its book value, which is the value of Day that is recorded on the company's balance sheet. Investors also form their own opinion of Day One's value that differs from its market value or its book value, called intrinsic value, which is Day One's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Day One's market value can be influenced by many factors that don't directly affect Day One's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Day One's value and its price as these two are different measures arrived at by different means. Investors typically determine if Day One is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Day One's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.